4//SEC Filing
Doyle John Brendan 4
Accession 0001104659-25-123721
CIK 0001455365other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:10 PM ET
Size
6.9 KB
Accession
0001104659-25-123721
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Award
Common Stock
2025-12-18+30,000→ 455,350 total - Tax Payment
Common Stock
2025-12-18$1.50/sh−9,360$14,040→ 445,990 total
Footnotes (2)
- [F1]Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.
Documents
Issuer
COGNITION THERAPEUTICS INC
CIK 0001455365
Entity typeother
Related Parties
1- filerCIK 0001840738
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:10 PM ET
- Size
- 6.9 KB